Tradestie Institutional Equity Comparison Engine
MBAI vs NDRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NDRA Overall Edge
NDRA Captures Institutional Edge (2โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ENDRA Life Sciences Inc. Common Stock (NDRA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, MBAI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NDRA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MBAI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MBAI N/M vs NDRA N/M Fwd P/E
Growth & Margin Winner
NDRA
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
NDRA
1Y +11.2% vs -32.7% ยท 52W Pos 12% vs 37%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MBAI
US Equity
MBAI
Institutional Equity
$2.08
+1.22% 1D
Market Cap
N/A
1M Return
-24.36%
1Y Return
+11.23%
Forward P/E
N/M
Unified AI Score
42.5 / 100
HOLD
Tech 26.0
Fund 47.0
Flow 50.0
Mom 60.0
NDRA
NASDAQ
ENDRA Life Sciences Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
+0.23% 1D
Market Cap
$6.6M
1M Return
-6.75%
1Y Return
-32.72%
Forward P/E
N/M
Unified AI Score
44.7 / 100
HOLD
Tech 35.0
Fund 46.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MBAI +11.23%
NDRA -32.72%
Spread: +36.44 pp (MBAI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MBAI TTM Op. Margin: N/A
NDRA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MBAI vs NDRA. Trailing 12-month operating profitability (MBAI N/A vs NDRA 0.0%) and valuation multiples (MBAI N/M vs NDRA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MBAI | NDRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $6.6M | Larger Scale | NDRA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | NDRA |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | NDRA |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | NDRA |
| Return on Equity (ROE) Capital Efficiency | N/A | -152.0% | Higher ROE | NDRA |
| 52-Week Range Position Momentum | 12% ($1โ$10) | 37% ($3โ$7) | Stronger Trend | NDRA |
| Beta / 30D Volatility Risk Regime | 3.78ฮฒ ยท 129% Vol | 0.71ฮฒ ยท 48% Vol | Lower Realized Risk | NDRA |
| Unified Institutional Score Composite Signal | 42.5 / 100 (HOLD) | 44.7 / 100 (HOLD) | Higher Composite | NDRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MBAI vs NDRA Buy Guide
MBAI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NDRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MBAI nor NDRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.